15th January, 2016
The Company Announcements Office ASX Limited
Level 4, Exchange Centre 20 Bridge Street
Sydney NSW 2000
This notice is given by Anteo Diagnostics Limted ("ADO") under sections 708A(5)(e) and 708A(6) of the Act.
Further to the announcement made by ADO on 6 January 2016, ADO has issued 82,742,554 shares on 11th January 2016 at 7.5 cents per share to investors without disclosure pursuant to section 708 of the Corporations Act 2001 (Cth) ("Act").
Accordingly, ADO gives this notice under section 708A(5)(e) of the Act, that:
The Shares are part of a class or ordinary shares quoted on ASX;
The Shares were issued without disclosure to investors under Part 6D.2 of the Act;
As at the date of this notice, ADO has complied with:
the provisions of Chapter 2M of the Act as they apply to ADO; and
section 674 of the Act.
As date the date of this notice, there is no excluded information, of the type referred to in sections 708A(7) and 708A(8) of the Act, which is required to be disclosed by ADO.
Yours faithfully
Richard Martin
Anteo Diagnostics Limted
Anteo Diagnostics Limited issued this content on 2016-01-14 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-14 22:03:19 UTC
Original Document: https://wcsecure.weblink.com.au/clients/anteodx/headline.aspx?headlineid=2901984